Full-Time

Manager – Medical Affairs

Confirmed live in the last 24 hours

Azurity Pharmaceuticals

Azurity Pharmaceuticals

201-500 employees

Develops specialized formulations of medicines

Biotechnology
Healthcare

Mid, Senior

Atlanta, GA, USA

Hybrid work model: 2 days from home, 3 days in the office.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Doctoral-level qualification (PharmD, PhD, MD) preferred, Master’s in a related field and 3+ years relevant experience may substitute.
  • A thorough understanding of the science and medical standards of care are essential.
  • Successful completion of pre-employment screening
  • 3+ years pharmaceutical or bio-tech industry experience
  • Ability to communicate highly scientific and technical medical information
  • Excellent communication / interpersonal skills / passion for excellence
  • Strong writing skills with demonstrated medical communications experience preferred
  • Demonstrated leadership ability
  • Effective administrative / organizational skills
  • Atlanta or Woburn home office-based preferred
Responsibilities
  • Effectively communicate and proactively lead the dissemination of evidence generation activities from the Medical Affairs organization, including the development and execution of Azurity’s publication strategy
  • Lead cross-functional team meetings and drive the production of scientific communications materials, often under tight timelines
  • Ensure that submitted materials are accurate, compliant, balanced, and of the highest quality
  • Develop, manage and provide input on several key programs/new initiatives within Azurity Medical Affairs, including manuscripts/publications, patient-focused materials, training materials, payer market materials, content for Advisory Board/Steering Committee meetings, dossier development, HEOR, Sales training programs, Azurity policies/SOPs and other materials required for Medical launch excellence
  • Manage external vendors and ensure that all materials are developed in a cost-effective manner and are consistent with the strategic thinking for a given product
  • Serve as Medical Affairs lead on all product reviews/assessments for lifecycle management (LCM) opportunities led by the Franchise Portfolio Management Heads and provide recommendation on behalf of Medical Affairs for all LCM review requests
  • Evaluate the established safety and efficacy profile of potential pipeline assets and FDA-approved product acquisition targets of strategic interest to Azurity
  • Educate/train/present key scientific medication and disease state information to internal (e.g., Sales, Marketing, Managed Care) and external stakeholders (e.g., health care practitioners, key thought leaders, advocacy groups, payers) for Azurity products
Azurity Pharmaceuticals

Azurity Pharmaceuticals

View

Azurity Pharmaceuticals develops specialized formulations of established medicines to meet the needs of patients often overlooked by other pharmaceutical companies. They focus on creating new dose forms, such as oral suspensions, that are easier to administer and absorb, particularly for those who have difficulty swallowing pills or need precise dosing. This approach enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity's products cover a wide range of therapeutic areas, including cardiovascular, central nervous system, endocrine, gastrointestinal, anti-infective, and oncology medicines. They serve healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines. Azurity's goal is to improve patient outcomes by providing high-quality, innovative medicines that address unmet medical needs.

Company Stage

Growth Equity (Venture Capital)

Total Funding

$182.2M

Headquarters

Woburn, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Azurity's acquisition of Slayback Pharma enhances its development portfolio for new medicine launches.
  • FDA approval of Myhibbin caters to the growing organ transplant recipient population.
  • Azmiro's launch positions Azurity as a leader in testosterone replacement therapy.

What critics are saying

  • Zenzedi recall due to packaging mix-up could harm Azurity's reputation and finances.
  • Slayback Pharma acquisition may lead to integration challenges and operational disruptions.
  • Azmiro faces competition from existing testosterone replacement therapies, affecting market penetration.

What makes Azurity Pharmaceuticals unique

  • Azurity focuses on innovative dose forms of established medicines for unmet needs.
  • Their FDA-approved products ensure safety and efficacy for overlooked patient populations.
  • Azurity's diverse therapeutic portfolio includes cardiovascular, CNS, endocrine, and oncology medicines.

Help us improve and share your feedback! Did you find this helpful?